Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Gold Price Monitor -- Ignore unavailable to you. Want to Upgrade?

To: long-gone who wrote (49234)	2/17/2000 11:47:00 AM
From: long-gone	Respond to of 116790

Then on the other side(at some point increasing) of world population growth: Stock Quotes Thrilling AIDS Discovery By Reed Williams, MD CNS Financial Analysis from StreetAdvisor.com 17 February, 2000 Human Genome Sciences (Nasdaq: HGSI) may hold in its hand a discovery that could prevent AIDS. Some people encounter poison ivy and never experience a reaction, while others are deathly allergic. The reason is that about 10% of our population express a gene that inhibits the allergic response to the stealthy culprit. When the AIDS epidemic first caught the world by storm, it was widely agreed that there was no protective mechanism that would prevent contraction of the HIV virus that causes AIDS. But several years ago, a small subset of people was discovered that engaged in repeated high-risk HIV activities yet never contracted the disease. Research passionately ensued in search of the protective mechanism that was responsible. Scientists discovered that these patients lacked a common receptor on the surface of their cells, known as the CCR5 receptor. This has led to the belief that the CCR5 receptor is a critical entry point for HIV into cells within the body. Without this receptor, HIV cannot enter the cells and is impotent in its attempt to replicate. (cont) conservativenews.org\Economics\archive\ECO20000217c.html